Catalan Life Sciences Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 21 - 40 out of 135 displayed.
« 1 2 3 4 5 6 7 »

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 16 Mar 2020

Novo Nordisk pauses the clinical trials investigating concizumab (anti-TFPI mAB) in haemophilia A and B with or without inhibitors

Read more ››

By: GlobenewsWire - 16 Mar 2020

Annual General Meeting in ALK-Abelló A/S held on 11 March 2020

Read more ››

By: GlobenewsWire - 11 Mar 2020

Novo Nordisk A/S: Share repurchase programme

Read more ››

By: GlobenewsWire - 09 Mar 2020

ALK-Abelló A/S' Annual General Meeting 2020

Read more ››

By: GlobenewsWire - 09 Mar 2020

Sanofi : Filing of the 2019 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report

Read more ››

By: GlobenewsWire - 05 Mar 2020

Allergy Therapeutics Interim Results for the six months ended 31 December 2019

Read more ››

By: GlobenewsWire - 04 Mar 2020

Related companies: Allergy Therapeutics Italia S.R.L. | Allergy Therapeutics plc | Allergy Therapeutics Ibérica, SL

Sanofi's Board of Directors proposes the appointment of Rachel Duan and Lise Kingo as independent directors

Read more ››

By: GlobenewsWire - 04 Mar 2020

Sanofi: Information on the Conditions for the Departure From Office of Olivier Brandicourt, Chief Executive Officer

Read more ››

By: GlobenewsWire - 04 Mar 2020

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

Read more ››

By: GlobenewsWire - 03 Mar 2020

Sanofi: Disclosure of trading in own shares

Read more ››

By: GlobenewsWire - 03 Mar 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 02 Mar 2020

Sanofi : FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma

Read more ››

By: GlobenewsWire - 02 Mar 2020

Sanofi: information concerning the total number of voting rights and shares, January 2020

Read more ››

By: GlobenewsWire - 25 Feb 2020

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 24 Feb 2020

ORYZON Reports Financial Results and Corporate Update for 4th Quarter and Year Ended December 31, 2019

Read more ››

By: GlobenewsWire - 24 Feb 2020

Related companies: Oryzon Genomics, S.A.

Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*)

Read more ››

By: GlobenewsWire - 24 Feb 2020

Sanofi: Disclosure of trading in own shares

Read more ››

By: GlobenewsWire - 24 Feb 2020

Notice for the Annual General Meeting of Novo Nordisk A/S

Read more ››

By: GlobenewsWire - 21 Feb 2020

Sanofi: Disclosure of trading in own shares

Read more ››

By: GlobenewsWire - 17 Feb 2020

« 1 2 3 4 5 6 7 »

Looking for companies outside of Catalonia?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

April 2020
- Online: BioTrinity 2020 - DIGITAL EVENT
May 2020
- : Venture Summit | West
- Vienna: Nano Drug Delivery 2020

Add an Event »

Latest company news

Sanofi finalizes Praluent® (alirocumab) restructuring with Regeneron
06 Apr 2020 (GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
06 Apr 2020 (GlobenewsWire)

Sanofi successfully prices taps on outstanding bond issues for EUR 500 million
06 Apr 2020 (GlobenewsWire)

Biotechgate database

About Biotechgate
The Catalan Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com